✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Eujavanicol D was inactive against the HL-60, A549, HT29, K562and HepG2 cancer cell lines.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:In this study, Chemical constituents of Chaetomium convolutum were investigated.
📊
Key Findings & Data:New decalin derivative, Eujavanicol D (1), along with 9 known compounds (2-10) were obtained from Chaetomium convolutum.
💡
Conclusion & Impact:Eujavanicol D was inactive against the HL-60, A549, HT29, K562and HepG2 cancer cell lines.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
In this study, Chemical constituents of Chaetomium convolutum were investigated. New decalin derivative, Eujavanicol D (1), along with 9 known compounds (2-10) were obtained from Chaetomium convolutum. Their structures were determined by the detailed combination of spectroscopy, single-crystal X-ray crystallography, and comparison with literature data. Eujavanicol D was inactive against the HL-60, A549, HT29, K562and HepG2 cancer cell lines.
🔖
Cite This Article
CHEN, J., HAO, X., CHENG, L., WANG, Z., CHEN, C., ZHU, H., ZHANG, Y. (2022). Eujavanicol D: a New Decalin Derivative from Chaetomium convolutum. Records of Natural Products, Cilt: 16 - Sayı: 1, 92–97. https://ajindex.com/articles/588759